Ocular Therapeutix Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Ocular Therapeutix stock has a consensus rating of "Strong Buy" and an average price target of $25.73. The average 1-year stock price forecast is 314.33% higher than the current stock price, while the lowest is $14 (+125.44%) and the highest is $34 (+447.50%).

Price Target: $25.73 (+314.33%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$14	$25.73	$28	$34
Change	+125.44%	+314.33%	+350.89%	+447.50%

Analyst Ratings

The average analyst rating for Ocular Therapeutix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	7	7	7	7	8	8
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $25 → $28	Buy	Reiterates	$25 → $28	+350.89%	Nov 10, 2026
Serge Belanger Needham	Needham	Buy Maintains $18	Buy	Maintains	$18	+189.86%	Nov 10, 2026
Lisa Walter RBC Capital	RBC Capital	Buy Reiterates $30	Buy	Reiterates	$30	+383.09%	Nov 10, 2026
Tazeen Ahmad Bank of America Securities	Bank of America Securities	Buy Reiterates $27	Buy	Reiterates	$27	+334.78%	Nov 10, 2026
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $31	Buy	Maintains	$31	+399.19%	Oct 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

51.00M

from 51.95M

-1.82%

from 51.95M

Revenue Next Year

91.18M

from 51.00M

78.78%

from 51.00M

EPS This Year

-1.51

from -1.42

EPS Next Year

-1.60

from -1.51

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	43.52M	51.49M	58.44M	63.72M	51.95M	51.00M
Revenue Growth	150.08%	18.32%	13.50%	9.03%	-18.47%	-1.82%
Operating Income	-78.04M	-78.65M	-82.38M	-160.88M	-270.02M	-373.70M
Net Income	-6.55M	-71.04M	-80.74M	-193.51M	-265.94M	-361.79M
EPS	-	-	-	-	-1.42	-1.51
Free Cash Flow	-	-	-	-	-216.89M	-321.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	53.5M
Avg	51.0M
Low	50.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	3.0%
Avg	-1.8%
Low	-3.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.27
Avg	-1.51
Low	-1.65

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-